SCOPUS 정보 검색 플랫폼

The Lancet

Volumn 385, Issue 9964, 2015, Pages 225-226

Rituximab for patients with nephrotic syndrome

(2) Shin, Jae Il a Kronbichler, Andreas b

a Yonsei University College of Medicine (South Korea)

b INNSBRUCK MEDICAL UNIVERSITY (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID; RITUXIMAB; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

CHILDHOOD DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFICACY; HUMAN; LETTER; NEPHROTIC SYNDROME; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; REMISSION; TREATMENT OUTCOME; FEMALE; MALE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NEPHROTIC SYNDROME;

EID: 84921293274 PISSN: 01406736 EISSN: 1474547X Source Type: Journal
DOI: 10.1016/S0140-6736(15)60050-2 Document Type: Letter

Times cited : (4)

References (5)

1
- 84917675536
- Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: A multicentre, double-blind, randomised, placebo-controlled trial
- on behalf of the Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group
- K Iijima, M Sako, K Nozu on behalf of the Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial Lancet 384 2014 1273 1281
- (2014) Lancet , vol.384 , pp. 1273-1281
- Iijima, K.¹ Sako, M.² Nozu, K.³

2
- 34247514826
- Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome
- HA Kyrieleis, EN Levtchenko, JF Wetzels Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome Am J Kidney Dis 49 2007 592 597
- (2007) Am J Kidney Dis , vol.49 , pp. 592-597
- Kyrieleis, H.A.¹ Levtchenko, E.N.² Wetzels, J.F.³

3
- 84921537150
- Non-corticosteroid treatment for nephrotic syndrome in children
- CD002290.
- EM Hodson, NS Willis, JC Craig Non-corticosteroid treatment for nephrotic syndrome in children Cochrane Database Syst Rev 10 2013 CD002290.
- (2013) Cochrane Database Syst Rev , vol.10
- Hodson, E.M.¹ Willis, N.S.² Craig, J.C.³

4
- 77956391149
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- JE Gottenberg, P Ravaud, T Bardin et al. Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry Arthritis Rheum 62 2010 2625 2632
- (2010) Arthritis Rheum , vol.62 , pp. 2625-2632
- Gottenberg, J.E.¹ Ravaud, P.² Bardin, T.³

5
- 34548837226
- Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy
- P Cravedi, P Ruggenenti, MC Sghirlanzoni, G Remuzzi Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy Clin J Am Soc Nephrol 2 2007 932 937
- (2007) Clin J Am Soc Nephrol , vol.2 , pp. 932-937
- Cravedi, P.¹ Ruggenenti, P.² Sghirlanzoni, M.C.³ Remuzzi, G.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.